Jane Street Group, LLC Trevena Inc Transaction History

Jane Street Group, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.16 - $100.0 $6,678 - $4.17 Million	-41,742 Reduced 69.77%	18,088 $3,000
Q2 2022 Aug 16, 2022	BUY	$0.2 - $0.5 $11,966 - $29,915	59,830 New	59,830 $25,000
Q1 2022 May 17, 2022	SELL	$0.41 - $0.63 $17,688 - $27,180	-43,143 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$0.57 - $1.29 $12,881 - $29,154	22,600 Added 110.01%	43,143 $25,000
Q3 2021 Nov 16, 2021	SELL	$1.11 - $1.7 $201,377 - $308,415	-181,421 Reduced 89.83%	20,543 $26,000
Q2 2021 Aug 16, 2021	BUY	$1.46 - $2.25 $248,202 - $382,504	170,002 Added 531.89%	201,964 $341,000
Q1 2021 May 18, 2021	BUY	$1.77 - $2.93 $9,681 - $16,027	5,470 Added 20.65%	31,962 $57,000
Q4 2020 Feb 17, 2021	BUY	$2.13 - $3.26 $56,427 - $86,363	26,492 New	26,492 $57,000
Q3 2020 Nov 17, 2020	SELL	$1.53 - $3.13 $129,973 - $265,893	-84,950 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$0.48 - $1.75 $40,776 - $148,662	84,950 New	84,950 $127,000
Q3 2019 Nov 14, 2019	SELL	$0.81 - $1.06 $39,979 - $52,318	-49,357 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$0.94 - $1.6 $46,395 - $78,971	49,357 New	49,357 $51,000
Q1 2019 May 16, 2019	SELL	$0.51 - $1.88 $17,829 - $65,722	-34,959 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$0.39 - $3.47 $13,634 - $121,307	34,959 New	34,959 $15,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $273M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.